BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37594195)

  • 1. Clinical outcomes using a 3D printed tandem-needle-template and the EMBRACE-II planning aims for image guided adaptive brachytherapy in locally advanced cervical cancer.
    Cobussen A; Petric P; Wulff CN; Buus S; Spejlborg H; Nielsen SK; Traberg A; Meisner B; Hokland S; Lindegaard JC
    Acta Oncol; 2023 Nov; 62(11):1470-1478. PubMed ID: 37594195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component.
    Fokdal L; Tanderup K; Hokland SB; Røhl L; Pedersen EM; Nielsen SK; Paludan M; Lindegaard JC
    Radiother Oncol; 2013 Apr; 107(1):63-8. PubMed ID: 23452917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
    Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of preplan-based three-dimensional individual template-guided brachytherapy compared to freehand implantation.
    Zhang B; Zhang S; Sun L; Wu Y; Yang Y
    J Appl Clin Med Phys; 2023 Mar; 24(3):e13840. PubMed ID: 36350283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a 3D-printed applicator for vaginal brachytherapy in patients with central pelvic-recurrent cervical cancer after primary hysterectomy.
    Qin X; Zhang F; Hou X; Yu L; Yu L; Yan J; Qiu J
    Brachytherapy; 2022; 21(2):193-201. PubMed ID: 34980568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
    Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
    Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
    Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design approach and benefits of the 3D-printed vaginal individualized applicator (VIA).
    Ewongwo A; Niedermayr T; Kidd EA
    Brachytherapy; 2024; 23(3):282-289. PubMed ID: 38402047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
    Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L
    Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of combined intracavitary/interstitial brachytherapy including oblique needles in locally advanced cervix cancer.
    Serban M; Fokdal L; Nielsen SK; Hokland SB; Hansen AT; Spejlborg H; Rylander S; Petric P; Lindegaard JC; Tanderup K
    Brachytherapy; 2021; 20(4):796-806. PubMed ID: 33994344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.
    Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ
    Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying 3D-Printed Templates in High-Dose-Rate Brachytherapy for Cervix Cancer: Simplified Needle Insertion for Optimized Dosimetry.
    Marar M; Simiele E; Niedermayr T; Kidd EA
    Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):111-119. PubMed ID: 35654306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direction Modulated Brachytherapy for Treatment of Cervical Cancer. II: Comparative Planning Study With Intracavitary and Intracavitary-Interstitial Techniques.
    Han DY; Safigholi H; Soliman A; Ravi A; Leung E; Scanderbeg DJ; Liu Z; Owrangi A; Song WY
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):440-448. PubMed ID: 27598809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome.
    Mahantshetty U; Sturdza A; Naga Ch P; Berger D; Fortin I; Motisi L; Schmid MP; Aravindakshan D; Ghadi Y; Swamidas JV; Chopra S; Gurram L; Nesvacil N; Kirisits C; Pötter R
    Radiother Oncol; 2019 Dec; 141():123-129. PubMed ID: 31495516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing Next-Generation 3-Dimensional Printing for Cervical Cancer Hybrid Brachytherapy: A Guided Interstitial Technique Enabling Improved Flexibility, Dosimetry, and Efficiency.
    Marar M; Niedermayr T; Kidd EA
    Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):312-320. PubMed ID: 37059235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes in cervical cancer patients treated by FDG-PET/CT-based 3-dimensional planning for the first brachytherapy session.
    Oh D; Huh SJ; Park W; Ju SG; Nam H; Lee JE
    Medicine (Baltimore); 2016 Jun; 95(25):e3895. PubMed ID: 27336876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Petersen JB; Nielsen SK; Lindegaard JC; Tanderup K
    Acta Oncol; 2008; 47(7):1337-43. PubMed ID: 18663651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.